Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer

Bevacizumab(Avastin(®)), a humanized therapeutic monoclonal antibody that targets vascular endothelial growth factor, is widely used in cancer treatment. Patients who are treated with bevacizumab have an increased risk of developing systemic hypertension. However, the relationship between bevacizuma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Nakaya, Aya, Kurata, Takayasu, Yokoi, Takashi, Iwamoto, Shigeyoshi, Torii, Yoshitaro, Katashiba, Yuichi, Ogata, Makoto, Hamada, Madoka, Kon, Masanori, Nomura, Shosaku
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944863/
https://ncbi.nlm.nih.gov/pubmed/27109438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.701
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars